Thermo Fisher Scientific Inc. is a global leader in serving science. The company's mission is to enable its customers to make the world healthier, cleaner, and safer. It serves customers in pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions, government agencies, and environmental and industrial research, development, quality, and process control settings. The company offers a wide range of products and services, including analytical instruments, life sciences solutions, specialty diagnostics, laboratory products, and biopharma services. Thermo Fisher continuously expands its capabilities through organic investments in R&D, capacity, capabilities, and acquisitions.

• Employees: 122,000 (as of December 31, 2023)
• Geographic Footprint: Americas, Asia Pacific, Europe, Middle East and Africa
• Headquarters: Waltham, Massachusetts
• Founded: Not Found
• Number of locations/facilities: Not Found
• Revenue: $42.86 billion (FY2023)
• Market Cap: $201.18 billion (as of June 30, 2023)
• Key Subsidiaries/Brands: Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon, PPD

• CEO: Marc N. Casper
• CFO: Stephen Williamson
• Board Chair: Marc N. Casper
• Other Key Executives: Michel Lagarde (Executive Vice President and Chief Operating Officer), Gianluca Pettiti (Executive Vice President), Michael A. Boxer (Senior Vice President and General Counsel), Lisa P. Britt (Senior Vice President and Chief Human Resources Officer), Joseph R. Holmes (Vice President and Chief Accounting Officer)

• Annual Revenue: $42.86 billion (FY2023)
• Net Income: $5.96 billion (FY2023)
• Market Cap: $201.18 billion (as of June 30, 2023)
• Total Assets: $98.73 billion (FY2023)
• Key Financial Highlights: Revenue decreased 5% compared to FY2022, GAAP operating income decreased 18%, adjusted operating income decreased 11%, GAAP diluted earnings per share decreased 12%, and adjusted earnings per share decreased 7%.

Thermo Fisher Scientific Inc. offers a wide range of products and services across four segments:

• Life Sciences Solutions: Reagents, instruments, and consumables for biological and medical research, drug discovery, and diagnostics.
• Analytical Instruments: Instruments, consumables, software, and services for various applications in pharmaceutical, biotechnology, academic, government, environmental, and industrial markets.
• Specialty Diagnostics: Diagnostic test kits, reagents, culture media, instruments, and associated products for healthcare, clinical, pharmaceutical, industrial, and food safety laboratories.
• Laboratory Products and Biopharma Services: Laboratory consumables, equipment, chemicals, and outsourced services for drug development, clinical research, and commercial drug manufacturing.

Thermo Fisher Scientific Inc. operates in four business segments:

• Life Sciences Solutions: $9.98 billion in revenue (FY2023)
• Analytical Instruments: $7.26 billion in revenue (FY2023)
• Specialty Diagnostics: $4.41 billion in revenue (FY2023)
• Laboratory Products and Biopharma Services: $23.04 billion in revenue (FY2023)

Thermo Fisher Scientific Inc.'s growth strategy focuses on three pillars:

• High-impact innovation
• Trusted partner status with customers
• Unparalleled commercial engine

The company invests in R&D, capacity expansion, and strategic acquisitions to enhance its capabilities and expand its market presence. It also focuses on developing new products and applications for its technologies, expanding service offerings, and improving customer service and support.

Thermo Fisher Scientific Inc. operates in the life sciences, analytical instruments, specialty diagnostics, and laboratory products industries. The company faces competition from a wide range of manufacturers, distributors, and service providers. Key competitive factors include technological innovation, price, service, delivery, product breadth, customer support, and e-business capabilities.

• Market Risks: Decline or slower-than-anticipated growth in the markets served, general economic conditions and related uncertainties, and foreign exchange rate fluctuations.
• Operational Risks: Reliance on sole or limited source suppliers, cybersecurity attacks and data breaches, and difficulty in attracting and retaining qualified personnel.
• Business Risks: Need to develop new products and adapt to technological changes, competition from existing and new products, and dependence on customer capital spending and government funding.